Sriram Ryali Caribou Biosciences, Inc. (CRBU) insider trading activity

CRBU Quotes by TradingView

Sriram Ryali is Chief Financial Officer of Caribou Biosciences, Inc.. Currently has a direct ownership of 17,360 shares of CRBU, which is worth approximately $23,262. The most recent transaction as insider was on Jan 29, 2025, when has been sold 17,360 shares (Common Stock) at a price of $1.42 per share, resulting in proceeds of $24,651. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4K
n/a 3M change
n/a 12M change
Total Value Held $23,262

Sriram Ryali Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 29 2025
BUY
Open market or private purchase
$24,651 $1.42 p/Share
17,360 Added 50.0%
17,360 Common Stock

Also insider at

CDXS
CODEXIS, INC. Healthcare
Chief Financial Officer
EIGR
Eiger BioPharmaceuticals, Inc. Healthcare
Chief Financial Officer
SR

Sriram Ryali

Chief Financial Officer
Palo Alto, CA

Track Institutional and Insider Activities on CRBU

Follow Caribou Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBU shares.

Notify only if

Insider Trading

Get notified when an Caribou Biosciences, Inc. insider buys or sells CRBU shares.

Notify only if

News

Receive news related to Caribou Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRBU